Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P950037/S285

Renamic Neo

Biotronik, Inc. · Decision date Apr 24, 2026

FDA DECISIONP950037/S285

What did the FDA approve?

FDA records P950037/S285 as a supplement to PMA P950037, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Apr 24, 2026.

FDA approval order statement

approval for display and programming head updates to Renamic Neo programmer
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Cardiovascular
Decision date
Apr 24, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
P950037/S285
Regulatory pathway
PMA supplement
Product code
DXY
Decision code
APPR
Decision date
Apr 24, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: implantable pacemaker Pulse-generator.

Product code
DXY
FDA device class
3

For the original device and its historical approval scope, see PMA P950037. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P950037 · Original PMA

    DROMOS DR/DR-A AND DROMOS SR/SR-B CARDIAC PACING SYSTEMS

  2. P950037/S275 · Related supplement

    Edora 8 DR-T (407145); Evity 8 DR-T (407146); Enitra 8 DR-T (407147); Enticos 8 DR-T (407148); Evity 6 DR-T (407149); En

  3. P950037/S276 · Related supplement

    Edora 8 DR-T (407145); Evity 8 DR-T (407146); Enitra 8 DR-T (407147); Enticos 8 DR-T (407148); Evity 6 DR-T (407149); En

  4. P950037/S277 · Related supplement

    Edora 8 DR-T; Evity 8 DR-T; Enitra 8 DR-T; Enticos 8 DR-T; Evity 6 DR-T; Enitra 6 DR-T; Edora 8 DR; Enitra 6 DR; Edora 8

  5. P950037/S278 · Related supplement

    Edora 8 DR-T 407145, Evity 8 DR-T 407146, Enitra 8 DR-T 407147, Enticos 8 DR-T 407148, Evity 6 DR-T 407149, Enitra 6 DR-

  6. P950037/S272 · Related supplement

    Edora 8 DR-T; Evity 8 DR-T; Enitra 8 DR-T; Enticos 8 DR-T; Evity 6 DR-T; Enitra 6 DR-T; Edora 8 DR; Enitra 6 DR; Edora 8

  7. P950037/S281 · Related supplement

    Siello T 53; Siello T 60; Siello JT 45; Siello JT 53; Solia T 53; Solia T 60; Solia JT 45; Solia JT 53; Siello S 45; Sie

  8. P950037/S274 · Related supplement

    Solia S 53 377177; Solia S 60 377179

  9. P950037/S285 received

    Application receipt date recorded by FDA.

  10. P950037/S284 · Related supplement

    DROMOS DR/DR-A AND DROMOS SR/SR-B CARDIAC PACING SYSTEMS

  11. P950037/S283 · Related supplement

    DROMOS DR/DR-A AND DROMOS SR/SR-B CARDIAC PACING SYSTEMS

  12. P950037/S280 · Related supplement

    Solia CSP S 53; Solia CSP S 60

  13. P950037/S286 · Related supplement

    Edora 8 DR-T (407145); Evity 8 DR-T (407146); Enitra 8 DR-T (407147); Enticos 8 DR-T (407148); Evity 6 DR-T (407149); En

  14. P950037/S287 · Related supplement

    Pulse Generator, Permanent Implantable Edora 8 DR-T Evity 8 DR-T Enitra 8 DR-T Enticos 8 DR-T Evity 6 DR-T Enitra 6 DR-T

  15. P950037/S282 · Related supplement

    Amvia-Solvia Pulse Generators Scan Duration Extension

  16. P950037/S285 · FDA decision

    Real-Time Process

  17. P950037/S290 · Related supplement

    Edora 8 DR-T, Evity 8 DR-T, Enitra 8 DR-T, Evity 6 DR-T, Enitra 6 DR-T, Edora 8 DR, Enitra 6 DR, Edora 8 SR-T, Evity 8 S

  18. P950037/S292 · Related supplement

    Drug Eluting Permanent Right Ventricular (RV) or Right Atrial (RA) Pacemaker Electrodes

  19. P950037/S293 · Related supplement

    Siello T 53, Siello T 60, Siello JT 45, Siello JT 53, Solia T 53, Solia T 60, Solia JT 45, Solia JT 53, Siello S 45, Sie

  20. P950037/S295 · Related supplement

    Solia T 53, Solia T 60, Solia S 45, Solia S 53, Solia S 60, Solia CSP S 53, Solia CSP S 60

  21. P950037/S291 · Related supplement

    PSW 2601.U, NEO 2601.U, Amvia Sky HF-T QP, Amvia Sky HF-T, Amvia Edge HF-T QP, Amvia Sky DR-T, Amvia Sky SR-T, Amvia Edg

  22. P950037/S279 · Related supplement

    Edora 8 DR-T 407145, Evity 8 DR-T 407146, Enitra 8 DR-T 407147, Enticos 8 DR-T 407148, Evity 6 DR-T 407149, Enitra 6 DR-

  23. P950037/S296 · Related supplement

    Edora 8 DR-T 407145; Evity 8 DR-T 407146; Enitra 8 DR-T 407147; Enticos 8 DR-T 407148; Evity 6 DR-T 407149; Enitra 6 DR-

  24. P950037/S298 · Related supplement

    Edora 8 DR-T, Evity 8 DR-T, Enitra 8 DR-T, Evity 6 DR-T, Enitra 6 DR-T, Edora 8 DR, Enitra 6 DR, Enticos 4 DR, Enticos

  25. P950037/S299 · Related supplement

    Edora 8 DR-T, Evity 8 DR-T, Enitra 8 DR-T, Enticos 8 DR-T, Evity 6 DR-T, Enitra 6 DR-T, Edora 8 DR, Enitra 6 DR, Edora 8

  26. P950037/S300 · Related supplement

    Amvia Sky DR-T, Amvia Sky SR-T; Amvia Edge DR-T, Amvia Edge SR-T; Solvia Rise DR-T, Solvia Rise SR-T; Amvia Sky HF-T QP,

Timeline entries are records held by MedtechLedger for P950037. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P950037

Product / regulatory recordCompanyPathwayDecision dateSource
Biotronik, Inc.PMA approvalOct 11, 1996FDA
Biotronik, Inc.PMA supplementSep 11, 2025FDA
Biotronik, Inc.PMA supplementSep 15, 2025FDA
Biotronik, Inc.PMA supplementOct 1, 2025FDA
Biotronik, Inc.PMA supplementOct 16, 2025FDA
Biotronik, Inc.PMA supplementOct 24, 2025FDA
Biotronik, Inc.PMA supplementDec 10, 2025FDA
Biotronik, Inc.PMA supplementDec 18, 2025FDA
Biotronik, Inc.PMA supplementFeb 3, 2026FDA
Biotronik, Inc.PMA supplementFeb 11, 2026FDA
Biotronik, Inc.PMA supplementFeb 12, 2026FDA
Biotronik, Inc.PMA supplementMar 5, 2026FDA
Biotronik, Inc.PMA supplementMar 27, 2026FDA
Biotronik, Inc.PMA supplementMar 30, 2026FDA
Solia CSP S LeadsP950037/S288
Biotronik, Inc.PMA supplementApr 2, 2026FDA
Biotronik, Inc.PMA supplementMay 7, 2026FDA
Biotronik, Inc.PMA supplementMay 15, 2026FDA
Biotronik, Inc.PMA supplementMay 28, 2026FDA
Biotronik, Inc.PMA supplementJul 1, 2026FDA
Solia CSP SP950037/S297
Biotronik, Inc.PMA supplementAug 27, 2026FDA
Biotronik, Inc.PMA supplementSep 17, 2026FDA
Biotronik, Inc.PMA supplementSep 25, 2026FDA
Biotronik, Inc.PMA supplementOct 9, 2026FDA
Biotronik, Inc.PMA supplementOct 13, 2026FDA
BIOexpressP950037/S289
Biotronik, Inc.PMA supplementOct 16, 2026FDA
Biotronik, Inc.PMA supplementOct 22, 2026FDA
Biotronik, Inc.PMA supplementOct 28, 2026FDA

Explore the linked device profile

Other records with product code DXY

Product / regulatory recordCompanyPathwayDecision dateSource
ABBOTT MEDICALPMA supplementJul 21, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Biotronik, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
6024 Jean Rd., Lake Oswego, OR, 97035

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records